Oculus Innovative Sciences to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

Download as PDF

Presentation and Live Webcast on Monday, February 16, 2009 at 2:40 p.m. PST

PETALUMA, Calif.--(BUSINESS WIRE)-- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) today announced that Hoji Alimi, the company's CEO and founder, will present a corporate overview and business update at the Roth Capital Partners 21st Annual OC Growth Stock Conference to be held at the Ritz Carlton in Laguna Niguel, California. Mr. Alimi's presentation is scheduled on Monday, February 16, 2009 at 2:40 p.m. PST, with a breakout session to immediately follow.

The presentation will be broadcast live and replayed for 90 days on Oculus Innovative Sciences' website at http://ir.oculusis.com/events.cfm. To listen to the live broadcast, please visit the website at least 15 minutes early to register and download any necessary audio software.

Participation in the conference is by invitation only. For more information on the conference, please contact your Roth representative or visit www.rothcp.com.

About Oculus

Oculus Innovative Sciences develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform features a biocompatible, shelf-stable solution containing active oxychlorine compounds that is currently commercialized in the United States, Europe, India, China and Mexico for the treatment of infected wounds. The solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores. The company's headquarters are in Petaluma, California, with operations in Europe and Latin America. More information can be found at www.oculusis.com.

Oculus and Microcyn are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the property of their respective owners. 


    Source: Oculus Innovative Sciences, Inc.

Released February 10, 2009